Welding's Generic (Posaconazole) Receives Approval in the U.S.
Welding`s Generic Cyanocobalamin Receives Approval in U.S.
Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Entecavir tablets USP, 0.5mg and 1mg, a generic version of Baraclude® Tablets by Bristol-Myers Squibb Company. The product, which was developed in collaboration with Welding GMBH & Co., is manufactured by RA Chem Pharma Limited and supplied to Breckenridge for exclusive distribution in the United States. Breckenridge will launch the product immediately.
German Drugmakers Appeal Drug Suspensions Linked to Indian Data
Malaria 2014 Deaths May Top 20,000 in Ebola-Hit Nations